EU MEDICINES AGENCY SAYS MARKETING AUTHORISATION FOR PFIZER VACCINE WOULD NEED TO BE AMENDED TO ALLOW EU-WIDE ADMINISTRATION OF SECOND DOSE MORE THAN 42 DAYS FROM FIRST
Market Closed -
Other stock markets
|
Pre-market 19:00:10 | |||
29.5 USD | +1.37% | 29.5 | 0.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.47% | 165B | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.41% | 126B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Eu Medicines Agency Says Marketing Authorisation For Pfizer Vaccine Would Need To Be Amended To Allow Eu-Wide Administration Of Second Dose More Than 42 Days From First